A
25.90
-2.37 (-8.37%)
| Previous Close | 28.26 |
| Open | 27.27 |
| Volume | 10,831,131 |
| Avg. Volume (3M) | 3,449,019 |
| Market Cap | 2,383,226,112 |
| Price / Earnings (Forward) | 19.08 |
| Price / Sales | 0.740 |
| Price / Book | 1.30 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2026 |
| Profit Margin | 5.94% |
| Operating Margin (TTM) | 10.19% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 0.30% |
| Quarterly Earnings Growth (YOY) | -89.00% |
| Total Debt/Equity (MRQ) | 74.09% |
| Current Ratio (MRQ) | 1.35 |
| Operating Cash Flow (TTM) | 462.46 M |
| Levered Free Cash Flow (TTM) | -276.20 M |
| Return on Assets (TTM) | 5.06% |
| Return on Equity (TTM) | 6.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | Acadia Healthcare Company, Inc. | Bullish | Bearish |
AIStockmoo Score
-0.5
| Analyst Consensus | -1.5 |
| Insider Activity | 3.0 |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | -0.50 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 109.93% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 28.00 (RBC Capital, 8.13%) | Buy |
| Median | 23.00 (-11.18%) | |
| Low | 20.00 (Barclays, -22.77%) | Hold |
| Average | 23.83 (-7.98%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 21.59 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 03 Mar 2026 | 20.00 (-22.77%) | Hold | 22.99 |
| Leerink Partners | 26 Feb 2026 | 22.00 (-15.04%) | Hold | 22.29 |
| RBC Capital | 26 Feb 2026 | 28.00 (8.13%) | Buy | 22.29 |
| TD Cowen | 26 Feb 2026 | 24.00 (-7.32%) | Buy | 22.29 |
| UBS | 26 Feb 2026 | 27.00 (4.27%) | Buy | 22.29 |
| Guggenheim | 23 Feb 2026 | 22.00 (-15.04%) | Buy | 17.38 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FARLEY BRIAN | 27.58 | - | 37,510 | 1,034,526 |
| Aggregate Net Quantity | 37,510 | |||
| Aggregate Net Value ($) | 1,034,526 | |||
| Aggregate Avg. Buy ($) | 27.58 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FARLEY BRIAN | Officer | 28 Apr 2026 | Acquired (+) | 37,510 | 27.58 | 1,034,526 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |